Susquehanna International Group, LLP Dynavax Technologies Corp Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$10.05 - $11.61 $160,800 - $185,760	16,000 Added 36.36%	60,000 $668,000
Q2 2024 Aug 15, 2024	SELL	$10.73 - $12.58 $1.64 Million - $1.93 Million	-153,200 Reduced 77.69%	44,000 $494,000
Q1 2024 May 07, 2024	BUY	$11.7 - $14.98 $1.37 Million - $1.76 Million	117,400 Added 147.12%	197,200 $2.45 Million
Q4 2023 Feb 14, 2024	BUY	$13.09 - $14.98 $378,301 - $432,922	28,900 Added 56.78%	79,800 $1.12 Million
Q3 2023 Nov 14, 2023	BUY	$12.64 - $14.99 $179,488 - $212,858	14,200 Added 38.69%	50,900 $751,000
Q2 2023 Aug 11, 2023	BUY	$9.85 - $13.17 $149,720 - $200,184	15,200 Added 70.7%	36,700 $474,000
Q1 2023 May 16, 2023	SELL	$9.44 - $11.88 $710,832 - $894,564	-75,300 Reduced 77.79%	21,500 $210,000
Q4 2022 Feb 14, 2023	SELL	$10.27 - $13.29 $2.72 Million - $3.52 Million	-264,700 Reduced 73.22%	96,800 $1.03 Million
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $753,687 - $1.32 Million	-75,900 Reduced 17.35%	361,500 $3.77 Million
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $198,915 - $342,561	26,700 Added 6.5%	437,400 $5.51 Million
Q1 2022 May 16, 2022	SELL	$9.75 - $14.44 $2.14 Million - $3.17 Million	-219,300 Reduced 34.81%	410,700 $4.45 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $775,713 - $1.23 Million	-58,900 Reduced 8.55%	630,000 $8.86 Million
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $2.81 Million - $6.09 Million	307,000 Added 80.39%	688,900 $13.2 Million
Q2 2021 Aug 11, 2021	SELL	$7.25 - $10.99 $742,400 - $1.13 Million	-102,400 Reduced 21.14%	381,900 $3.76 Million
Q1 2021 May 17, 2021	SELL	$4.57 - $11.18 $414,499 - $1.01 Million	-90,700 Reduced 15.77%	484,300 $4.76 Million
Q4 2020 Feb 16, 2021	SELL	$3.73 - $5.6 $230,514 - $346,080	-61,800 Reduced 9.7%	575,000 $2.56 Million
Q3 2020 Nov 16, 2020	BUY	$4.32 - $11.7 $1.12 Million - $3.03 Million	259,400 Added 68.73%	636,800 $2.75 Million
Q2 2020 Aug 14, 2020	BUY	$2.94 - $9.1 $823,788 - $2.55 Million	280,200 Added 288.27%	377,400 $3.35 Million
Q1 2020 May 15, 2020	SELL	$2.27 - $6.2 $108,960 - $297,600	-48,000 Reduced 33.06%	97,200 $343,000
Q4 2019 Feb 14, 2020	BUY	$3.46 - $6.93 $173,346 - $347,193	50,100 Added 52.68%	145,200 $831,000
Q3 2019 Nov 14, 2019	SELL	$2.69 - $4.85 $249,094 - $449,109	-92,600 Reduced 49.33%	95,100 $340,000
Q2 2019 Aug 14, 2019	SELL	$3.65 - $7.89 $1.08 Million - $2.34 Million	-296,400 Reduced 61.23%	187,700 $749,000
Q1 2019 May 15, 2019	SELL	$7.08 - $12.09 $77,880 - $132,990	-11,000 Reduced 2.22%	484,100 $3.54 Million
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $167,684 - $273,568	20,600 Added 4.34%	495,100 $4.53 Million
Q3 2018 Nov 14, 2018	SELL	$11.85 - $16.0 $452,670 - $611,200	-38,200 Reduced 7.45%	474,500 $5.88 Million
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $4.92 Million - $6.74 Million	324,600 Added 172.57%	512,700 $7.82 Million
Q1 2018 May 15, 2018	SELL	$14.65 - $19.9 $2.11 Million - $2.87 Million	-144,100 Reduced 43.38%	188,100 $3.73 Million
Q4 2017 Feb 14, 2018	BUY	$17.3 - $24.08 $2.24 Million - $3.12 Million	129,400 Added 63.81%	332,200 $6.21 Million
Q3 2017 Nov 14, 2017	BUY	$15.2 - $21.5 $3.08 Million - $4.36 Million	202,800	202,800 $4.36 Million

Others Institutions Holding DVAX

# of Institutions

273

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

Black Rock Inc. New York, NY

21.9M
Shares

$267 Million
0.01% of portfolio
Deep Track Capital, LP Greenwich, CT

12.5M
Shares

$152 Million
5.15% of portfolio
Vanguard Group Inc Valley Forge, PA

9.22M
Shares

$112 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

8.33M
Shares

$101 Million
7.62% of portfolio
State Street Corp Boston, MA

7.69M
Shares

$93.6 Million
0.0% of portfolio

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.54B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account